Mitchel Leavitt, MD
Physical Medicine & Rehabilitation · Athens, GANPI 1528204823
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $435 of the $658 with a category attached, or 66.0%. 5 manufacturers reported payments, led by Boston Scientific at 52.1% of the total. 2024 is the largest year on record at $237, more than ten times the $18 reported in 2019.
Across 14 payments — averaging $47.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$343
- Nevro Corp.$154
- Abbott$87
- Amgen$61
- Pacira Therapeutics, Inc.$14
What the payments were for
- Travel & lodging$22434%
- Food & beverage$43566%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $343 |
| Nevro Corp. | 3 | $154 |
| Abbott | 2 | $87 |
| Amgen | 4 | $61 |
| Pacira Therapeutics, Inc. | 1 | $14 |
How this compares
$658 in reported general payments places this provider in the 65th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 376 | $7,384 |
| Pregabalin | 250 | $4,230 |
| Gabapentin | 374 | $3,929 |
| Baclofen | 350 | $3,363 |
| Tramadol Hcl | 388 | $2,116 |
| Lidocaine | 23 | $1,776 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 101 | $1,752 |
| Methocarbamol | 86 | $989 |
| Diclofenac Sodium | 90 | $936 |
| Tizanidine Hcl | 123 | $809 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 44 | $664 |
| Diazepam | 540 | $448 |
| Celecoxib | 28 | $440 |
| Oxycodone Hcl | 32 | $403 |
| Duloxetine Hcl | 25 | $251 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Athens
- Christopher DoerrAthens$4K
- Erik ShawAtlanta$175K
- David TranAlpharetta$96K
- Payal FadiaDecatur$66K
- John MusserStockbridge$57K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald ChaiLawrenceville$16K
- Gerald BilskyAtlanta$16K
- Aiwane IboayaColumbus$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.